These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26509454)

  • 1. [Low dose naltrexone for treatment of pain].
    Plesner KB; Vægter HB; Handberg G
    Ugeskr Laeger; 2015 Oct; 177(43):V03150248. PubMed ID: 26509454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders.
    Patten DK; Schultz BG; Berlau DJ
    Pharmacotherapy; 2018 Mar; 38(3):382-389. PubMed ID: 29377216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
    Younger J; Noor N; McCue R; Mackey S
    Arthritis Rheum; 2013 Feb; 65(2):529-38. PubMed ID: 23359310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A morphine/naltrexone combination (Embeda) for pain.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):22-3. PubMed ID: 20336033
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review.
    Kim PS; Fishman MA
    Curr Pain Headache Rep; 2020 Aug; 24(10):64. PubMed ID: 32845365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy.
    Li Z; You Y; Griffin N; Feng J; Shan F
    Int Immunopharmacol; 2018 Aug; 61():178-184. PubMed ID: 29885638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Naltrexone--high expectations to low dosages].
    Raknes G; Giverhaug T
    Tidsskr Nor Laegeforen; 2011 May; 131(8):844-6. PubMed ID: 21556092
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibromyalgia.
    Johnson J; Sheth S
    J Pain Palliat Care Pharmacother; 2016 Sep; 30(3):233-4. PubMed ID: 27636677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is fibromyalgia an endocrine/endorphin deficit disorder? Is low dose naltrexone a new treatment option?
    Ramanathan S; Panksepp J; Johnson B
    Psychosomatics; 2012; 53(6):591-4. PubMed ID: 22480625
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database.
    Raknes G; Småbrekke L
    Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):685-693. PubMed ID: 28370746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing acupuncture by low dose naltrexone.
    Hesselink JM; Kopsky DJ
    Acupunct Med; 2011 Jun; 29(2):127-30. PubMed ID: 21415049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial.
    Sharafaddinzadeh N; Moghtaderi A; Kashipazha D; Majdinasab N; Shalbafan B
    Mult Scler; 2010 Aug; 16(8):964-9. PubMed ID: 20534644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of naltrexone in the treatment of chronic pain: a systematic review.
    Rassi-Mariani V; Barreto ESR; Antunes CR; Alencar VB; Falcão Lins-Kusterer LE; Azi LMTA; Kraychete DC
    Pain Manag; 2024; 14(8):453-463. PubMed ID: 39301937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial.
    Bruun KD; Amris K; Vaegter HB; Blichfeldt-Eckhardt MR; Holsgaard-Larsen A; Christensen R; Toft P
    Trials; 2021 Nov; 22(1):804. PubMed ID: 34781989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-low dose oral naltrexone decreases side effects and potentiates the effect of methadone.
    Cruciani RA; Lussier D; Miller-Saultz D; Arbuck DM
    J Pain Symptom Manage; 2003 Jun; 25(6):491-4. PubMed ID: 12782427
    [No Abstract]   [Full Text] [Related]  

  • 16. Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability.
    Turel AP; Oh KH; Zagon IS; McLaughlin PJ
    J Clin Psychopharmacol; 2015 Oct; 35(5):609-11. PubMed ID: 26203498
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes.
    Trofimovitch D; Baumrucker SJ
    Am J Hosp Palliat Care; 2019 Oct; 36(10):907-912. PubMed ID: 30917675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of buprenorphine antinociception with ultra-low dose naltrexone in healthy subjects.
    Hay JL; La Vincente SF; Somogyi AA; Chapleo CB; White JM
    Eur J Pain; 2011 Mar; 15(3):293-8. PubMed ID: 20728384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Dose Naltrexone in the Treatment of Fibromyalgia.
    Metyas S; Chen CL; Yeter K; Solyman J; Arkfeld DG
    Curr Rheumatol Rev; 2018; 14(2):177-180. PubMed ID: 28325149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Dose Naltrexone in Dermatology.
    Jaros J; Lio P
    J Drugs Dermatol; 2019 Mar; 18(3):235-238. PubMed ID: 30909326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.